Kang L. M. et al. (2018) Tetracycline-responsive promoters: A review of the role of the Tn10 promoter in gene expression in mammalian cells. Molecular Cloning Methods. 10th ed. New York: New York University Press.
Sokolovich, D. A. (2008) The Tn10 T-rich element and its regulation. Nucleic Acids Res. 12: 1733–1809.
Teng L, Li, et al. (2013) Tetracycline-responsive promoter: A systematic review. PLoS Negl Int. 4: e1009.
(2013) Tetracycline-responsive promoters: A review.
Gangeshi, V. (2016) TetR-mediated gene expression in mammalian cells: A review. 11: 1481–1507.
(2013) Tetracycline-responsive promoters and a review of the roles of the T-rich sequence in mammalian gene expression.
Zhang, B. (2014) Tetracycline-responsive promoters and their regulation. 4: e1004.
Meyer, G. (2011) Tetracycline-responsive promoters in mammalian cells. 12: 1320–1325.
Luo, K. (2016) The Tn10 T-rich element: a review of its regulatory function. Cell Fortschr. 24: 39–44.
(2017) The Tn10 T-rich element: a review of its regulatory function and regulation. 24: 40–46.
Kanohashi, T. (2017) The Tn10 T-rich element: a review of the regulatory function of the T-rich sequence. 24: 47–68.
Hsu, Y. (2012) The Tn10 T-rich element: a review of its regulatory function and regulation. 25: 477–500.
Zhou, J. (2011) Tetracycline-responsive promoters and their regulation. 3: e1009.
(2012) The Tn10 T-rich element and its regulation. 26: 1485–1509.
Wu, X. (2015) Tetracycline-responsive promoters in mammalian cells. 4: e1005.
Shen Y, Li, et al. 24: 38–44.
Yun L, Wang J. 11: e1009.
Zhang, Z. (2016) Tetracycline-responsive promoters in mammalian cells. 12: 1481–1507.
(2017) The Tn10 T-rich element: a review of the regulatory function and regulation.
Tetracycline belongs to the 'antibiotics' class, primarily used to treat bacterial infections. Tetracycline is also used to treat sexually transmitted diseases, such as syphilis, gonorrhoea, or chlamydia. Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly.
Tetracycline contains 'Tetracycline' a broad-spectrum antibiotic. It works by preventing the synthesis of bacterial proteins, which are the primary cursors for carrying out bacteria's vital functions. This process further inhibits bacterial growth.
Your doctor will decide the dose and duration of the course based on the severity of your disease. Like all medicines, Tetracycline also causes side effects, although not everybody gets them. Common side effects of Tetracycline include nausea, vomiting, diarrhoea, loss of appetite, mouth sores, black hairy tongue, sore throat, dizziness, headache, and rectal discomfort. If any of these effects persist or worsen, seek medical advice promptly.
Brief your medical history to the doctor, if you are allergic to Tetracycline or any of its components. It is advised to consult your doctor if you are pregnant or breastfeeding before taking Tetracycline. Avoid taking alcohol while using Tetracycline since it may worsen the side effects. Tetracycline can make you feel dizzy, hence drive or operate machinery only when you are alert. Tetracycline is not recommended in children below eight years of age since it causes permanent tooth discolouration.
How should I take Tetracycline? Some forms of Tetracycline are taken by mouth, without regard to meals. Do not take more than the recommended dose to achieve effective treatment. The usual adult dose of Tetracycline is 250 mg taken once a day at the same time every day.Take Tetracycline exactly as prescribed by your doctor. Do not take more than the recommended dose in one day. Follow the instructions given by your doctor to your letter. Take only the medication prescribed and not to exceed the recommended dose.
The usual dose of Tetracycline is 500 mg taken once a day at the same time every day.
The course of treatment should be completed as soon as possible. However, if the course is already late or has not been completed for a long period, do not ignore the completion of the course without consulting your doctor. Do not stop taking this medication suddenly, since it may affect your ability to absorb calcium and ironaquin by your mother's milk. Inform your doctor about any medical conditions you have, since Tetracycline may affect your fertility. Your doctor will decide how you should use this medicine.
Can I take Tetracycline if I am pregnant or breastfeeding? Tetracycline is excreted in the breast milk. Do not take this medicine if you are pregnant or breast-feeding. The use of this medicine during pregnancy or while you are breastfeeding is not recommended. Consult your doctor if you are pregnant or breast-feeding while you are using this medicine.Can I take Tetracycline if I have kidney disease? If you are taking Tetracycline, you must not take this medicine if you have kidney disease. It is important to inform your doctor about all the medicines you are taking, including medicines you take while you have kidney disease. This will help prevent possible toxicity from taking this medicine. This medicine should not be used during pregnancy and while you are breast-feeding.
How long does it take for Tetracycline to work? Tetracycline normally starts to work within 1 to 2 weeks of taking it. However, it may take longer to become effective if you take it for a longer period of time than prescribed by your doctor. Avoid taking alcohol while using Tetracycline as it may worsen the effectiveness of this medicine. Your doctor will decide how you should use this medicine based on your medical condition. Your doctor may also monitor your temperature, which can be especially sensitive to heat. Remember that your doctor has prescribed this medicine for you.Tetracycline usually takes 30 to 60 minutes to take effect. However, it may take longer to start working in a short time. Tetracycline should not be taken with food or milk.The pathogenesis of tetracycline-resistant infections is complex, with multiple functions attributed to the diverse host response to the drug [
,
]. Tetracyclines inhibit bacterial protein synthesis, resulting in cell death of bacterial cells. These effects are associated with the inhibition of protein synthesis in a bacterium (i.e., the growth and death of the parent cell) and a decrease of cell death due to cell division [
Tetracyclines are generally well tolerated and have a low toxicity. However, some severe cases, such as those associated with the treatment of anorectal infections, may require prolonged treatment of the gastrointestinal tract [
Tetracyclines have a broad spectrum of activity against various pathogens, including gram-positive and gram-negative bacteria, e.g.,
Streptococcus pneumoniae,Escherichia coli, and some other gram-negative pathogens, such as
Salmonellaand
Shigella; some strains ofEnterococcus
BartonellaPasteurella; and a wide range of Gram-negative bacteria, including
Enterobacter,ProteusShigella,Campylobacter,Pseudomonas; in addition, some
species have been found to cause severe infections [
The role of tetracyclines in the development of theStaphylococcusspp. is supported by the recent report of the first study on the relationship betweenand the development of an infection, which revealed a high prevalence ofin the community, especially in patients with underlyingorStaphylococcus aureusinfections [
In addition, the mechanism of bacterial resistance to tetracyclines is not well-understood, and the effects of tetracyclines on the development of bacterial resistance to this drug are unknown. To date, the drug
BacteroidesClostridiumspp.,
PeptococcusEscherichiahave been reported to have antimicrobial effects. However, the mechanisms of resistance and its consequences on bacterial fitness are still unknown. This study aimed to address the mechanisms of tetracycline resistance and its clinical relevance in bacterial infections.
The tetracyclines (Aminoglycosides, sulfonamide derivatives and antibiotics) were obtained from Sigma-Aldrich (St. Louis, MO, USA).
The cDNA of thewas cloned into the pGBM-l plasmid, and the cDNA of theEscherichia coliwas cloned into the pGL4.5 (Invitrogen) by using the following conditions: overnight at 37°C, the cDNA was reverse transcribed into plasmid DNA using a High Capacity PCR-High-Cost PCR Kit (Applied Biosystems, Foster City, CA, USA).
Tetracycline hydrochloride is a synthetic antibiotic of the tetracycline group. It is widely used in veterinary medicine, as an immunosuppressant, as an antibiotic, a bacteriostatic, a growth promoter, and a tumor promoter.
Tetracycline hydrochloride is available as tablets and suspension.
Hypersensitivity to tetracycline hydrochloride or any other component of the formulation.
The risk of serious allergic reactions in dogs, cats, and horses is increased when used as a systemic drug. The tetracycline hydrochloride tablets, suspension, and chewable tablets should be used with caution in animals with hypersensitivity reactions to tetracyclines.
The tetracycline hydrochloride tablets and chewable tablets should be used with caution in animals with hypersensitivity to other tetracyclines, as their use is generally not recommended.
The tetracycline hydrochloride tablet and chewable tablets should not be used together. This may cause side effects such as stomach irritation or diarrhea, which can be fatal.
Tetracycline hydrochloride is available in the form of tablets and suspension. However, the tetracycline hydrochloride is available in tablet forms in the form of suspension, chewable tablets, and soluble tablets. Therefore, the use of the tetracycline hydrochloride tablet and chewable tablets should be avoided during pregnancy or while breastfeeding.
The following drugs, when used together, may increase the risk of side effects: warfarin, erythromycin, methotrexate, penicillin, and others. Concomitant use of these drugs with tetracycline hydrochloride may result in increased blood levels of the drug, leading to an increased risk of bleeding. Tetracycline hydrochloride may be given with or without food.
The use of tetracycline hydrochloride in pregnant or lactating animals is not recommended. Use of the tetracycline hydrochloride should be avoided if possible, as this may result in an increased risk of drug accumulation, especially during lactation.
Use of the tetracycline hydrochloride tablets and chewable tablets should be discontinued at regular intervals and for at least 6 months after the last dose. This will help to prevent drug resistance and ensure that the tetracycline hydrochloride is not used more than necessary.
Tetracycline hydrochloride should not be used during pregnancy. It should be used in accordance with the current recommendations and guidelines for use of tetracyclines in animals. It is also recommended to monitor for signs of an allergic reaction, such as hives, difficulty breathing, swelling, or difficulty in breathing after taking the drug.
The use of the tetracycline hydrochloride tablets and chewable tablets should be discontinued at regular intervals and for at least 6 months after the last dose. This will help to prevent drug accumulation and ensure that the tetracycline hydrochloride is no longer used. Tetracycline hydrochloride should be stored at room temperature (23°C) and away from heat.
It is recommended that the use of tetracycline hydrochloride is avoided in pregnant animals. Tetracycline hydrochloride may lead to serious, life-threatening allergic reactions, including anaphylactoid reactions. It is recommended that the use of tetracycline hydrochloride be avoided during pregnancy. Tetracycline hydrochloride should be used only when clearly needed and in the absence of contraindications.
The typical dosage of tetracycline hydrochloride for oral use in acne is 1 mg/kg body weight for adults. The dose depends on the severity of acne and the individual's health. For moderate acne, the recommended dosage is 1 mg/kg body weight per day. For severe acne, the recommended dosage is 2 mg/kg body weight per day. In general, the oral treatment is best suited for individuals with moderate acne. The dosage of tetracycline hydrochloride for oral use in acne depends on the severity of acne, and may be adjusted based on a number of factors, such as age and body weight.
2. Dosage Forms and Strengths
The dosage forms of tetracycline hydrochloride for oral use in acne are as follows:
Tablets: 10 mg/kg body weight per day
Tablets: 20 mg/kg body weight per day
Tablets: 40 mg/kg body weight per day
Tablets: 80 mg/kg body weight per day
Tablets: 100 mg/kg body weight per day
Tablets: 200 mg/kg body weight per day
Tablets: 400 mg/kg body weight per day
Tablets: 600 mg/kg body weight per day
Tablets: 800 mg/kg body weight per day
Tablets: 1600 mg/kg body weight per day
Tablets: 300 mg/kg body weight per day
3.
Stade de France Pharmacy